Free Newsletter
India reports change in fakes-distribution tactic
Racketeers have changed the game in India, delivering small quantities of counterfeit drugs to avoid seizure and conceal both source and supply route. The practice contrasts with more common bulk consignments, in which carriers pick up quantities from sites that make the fakes but entire shipments are vulnerable to seizure if detected.
The new method makes it difficult for investigators to find the source of supply, reports the Times of India. Those caught carrying the fakes know only the person who supplies them, rather than the actual source.
Police last week arrested one person and recovered 7,500 tablets of blood-pressure medication Listril and 60 units of hemorrhage drug Octride-100. Their packaging displays phony trademarks. Officials say the market value of the recovered medicines is about $1,600.
Cardiovascular treatments are among the most often counterfeit of drugs.
- see the article
Related Articles:
Chinese made-in-India fakes seized by regulators
India steps up control of imports
India seeks anti-fakes tools to preserve reputation
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: